Complete mandatory fasting for 8 hours, preoperative cardiac imaging (ECHO/CT), coagulation profile correction, administration of prophylactic antibiotics, and placement of central venous and arterial access.
Admission to Cardiac Intensive Care Unit (CICU) for continuous hemodynamic monitoring, titration of inotropic support, systemic anticoagulation management, physical therapy, and eventual transfer to telemetry ward prior to discharge.
Comprehensive Guide to Right Ventricular Assist Device (RVAD) Implantation
1. Introduction and Clinical Overview
The Right Ventricular Assist Device (RVAD) is a sophisticated mechanical circulatory support system designed to provide temporary or durable hemodynamic support for patients suffering from acute or chronic right-sided heart failure. While Left Ventricular Assist Devices (LVADs) are more commonly discussed in clinical literature, the RVAD serves a critical role in managing patients whose right ventricles are unable to maintain adequate pulmonary circulation.
The right ventricle (RV) is a highly compliant, thin-walled chamber that is particularly sensitive to pressure overload. When the RV fails—often secondary to left-sided heart failure, myocardial infarction, or pulmonary hypertension—the systemic venous return is impeded, leading to profound congestion and end-organ dysfunction. RVAD implantation is a life-saving intervention that bypasses the failing right ventricle, drawing blood from the right atrium or ventricle and pumping it directly into the pulmonary artery.
2. Technical Specifications and Mechanisms
An RVAD operates as a centrifugal or axial flow pump, acting as a "bridge" to recovery, a bridge to decision, or a bridge to transplant.
Mechanism of Action
The device creates a pressure gradient that facilitates blood flow from the venous systemic circulation to the pulmonary vascular bed. By reducing the preload on the right ventricle, the RVAD allows for myocardial rest, which can facilitate recovery in cases of acute myocarditis or post-cardiotomy shock.
Components of the System
- Inflow Cannula: Typically inserted into the right atrium (RA) or the right ventricle (RV) apex to collect deoxygenated venous blood.
- Pump Head: A high-speed impeller mechanism that provides continuous or pulsatile flow.
- Outflow Graft: A synthetic vascular conduit (Dacron or PTFE) that connects the pump to the main pulmonary artery.
- Controller/Driver: The external power source that monitors flow rates, speed (RPM), and alarm parameters.
3. Clinical Indications and Usage
The decision to implant an RVAD is governed by rigorous hemodynamic assessment. The primary objective is to maintain adequate cardiac output while preventing the "vicious cycle" of right heart failure.
Table 1: Primary Indications for RVAD Implantation
| Indication | Clinical Context |
|---|---|
| Post-Cardiotomy Shock | Failure to wean from cardiopulmonary bypass (CPB) after complex cardiac surgery. |
| Acute RV Myocardial Infarction | Massive infarction leading to cardiogenic shock with refractory hypotension. |
| Pulmonary Embolism | Severe obstructive shock resulting in acute right heart failure. |
| Post-LVAD Placement | "RV failure" occurring after the implantation of an LVAD, requiring biventricular support (BiVAD). |
| End-stage Heart Failure | As part of a destination therapy plan when transplant is not immediately feasible. |
Patient Selection Criteria
Candidates must be evaluated for:
1. Hemodynamic Instability: Inotrope-refractory hypotension or cardiac index < 2.0 L/min/m².
2. Central Venous Pressure (CVP): Persistent elevation (> 18-20 mmHg) despite aggressive diuresis.
3. End-Organ Function: Absence of irreversible multi-organ failure (e.g., severe hepatic or renal necrosis).
4. Pre-Operative Preparation
Preparation for RVAD implantation is a multidisciplinary effort involving cardiac surgeons, perfusionists, intensivists, and cardiologists.
Steps in Pre-Op Optimization:
- Imaging: Transthoracic (TTE) and Transesophageal Echocardiography (TEE) to assess RV size, function, and presence of intracardiac thrombus.
- Laboratory Analysis: Comprehensive coagulation profile, renal function (Creatinine/BUN), and liver function tests.
- Infection Prophylaxis: Administration of weight-based prophylactic antibiotics.
- Anticoagulation: Baseline assessment of the coagulation cascade; heparin drip management if the patient is already on mechanical support (e.g., ECMO).
5. The Procedure: Detailed Steps
RVAD implantation is typically performed via median sternotomy, although minimally invasive approaches are becoming more common in specific centers.
- Sternotomy and Exposure: Standard median sternotomy is performed. If the patient is already on CPB, the heart is kept decompressed.
- Cannulation:
- Inflow: The right atrium is exposed. A purse-string suture is placed, and the inflow cannula is inserted, secured with heavy braided sutures.
- Outflow: The main pulmonary artery (PA) is mobilized. A side-biting clamp is applied, and the outflow graft is anastomosed to the PA.
- Driveline Tunneling: The pump cable is tunneled through the subcutaneous tissue to exit the abdominal wall, creating a secure exit site to prevent infection.
- De-airing: Meticulous de-airing of the pump and graft is performed to prevent systemic or pulmonary embolization.
- Initiation of Support: The pump is gradually ramped up while weaning the patient from cardiopulmonary bypass. Hemodynamics are monitored in real-time.
- Closure: Standard closure of the sternum with stabilization wires.
6. Post-Operative Recovery Protocol
Recovery is managed in the Cardiac Intensive Care Unit (CICU).
Critical Care Focus Areas:
- Hemodynamic Monitoring: Target CVP 8–12 mmHg; monitor pulmonary artery pressure (PAP).
- Anticoagulation Management: Transition to therapeutic heparin infusion, followed by warfarin (or antiplatelet therapy, depending on the device type).
- Infection Control: Daily dressing changes at the driveline exit site using sterile technique.
- Rehabilitation: Early physical therapy is essential to prevent muscle atrophy, even while the patient is on mechanical support.
7. Potential Complications
Despite the life-saving potential, RVAD implantation carries significant risks:
- Bleeding: Often related to the systemic anticoagulation required to prevent pump thrombosis.
- Infection: Driveline infections are the most common long-term complication.
- Thromboembolism: Pump thrombosis can lead to catastrophic failure or stroke (if a PFO is present).
- Right-to-Left Shunting: If a Patent Foramen Ovale (PFO) exists, the pressure changes may cause paradoxical emboli or desaturation.
- Device Malfunction: Mechanical failure of the impeller or controller.
8. Alternative Treatments
When RVAD is not feasible or appropriate, clinicians may consider:
* Inotropic Therapy: Milrinone or Dobutamine (often ineffective in severe failure).
* Inhaled Nitric Oxide (iNO): To reduce pulmonary vascular resistance.
* Venovenous (VV) or Venoarterial (VA) ECMO: A temporary alternative that provides both cardiac and respiratory support.
* Total Artificial Heart (TAH): For patients with biventricular failure who are candidates for transplant.
9. Frequently Asked Questions (FAQ)
1. How long can a patient stay on an RVAD?
The duration depends on the clinical goal. It can be days (for acute recovery) or months (as a bridge to transplant).
2. Is RVAD surgery painful?
Post-operative pain is managed with regional anesthesia, nerve blocks, and systemic analgesics.
3. What is the difference between an RVAD and an LVAD?
An RVAD supports the right side of the heart (pulmonary circulation), whereas an LVAD supports the left side (systemic circulation).
4. Can a patient walk with an RVAD?
Yes, modern portable controllers allow patients to ambulate, which is crucial for recovery.
5. What are the signs of pump failure?
Signs include sudden hypotension, alarms from the controller, and rising CVP.
6. Do all patients with RV failure need an RVAD?
No; many patients respond to aggressive medical management and pulmonary vasodilators.
7. What is the risk of stroke?
The risk is generally lower than with LVADs because the blood is pumped into the pulmonary system, but it remains a consideration if a PFO is present.
8. How is the driveline exit site managed?
It requires strict sterile care to prevent bacteria from tracking into the mediastinum.
9. Can I get an MRI with an RVAD?
Most RVADs are not MRI-compatible. Always consult the specific device manufacturer's guidelines.
10. What happens if the power fails?
All RVAD systems have battery backups and manual hand-pumps for emergency scenarios.
10. Conclusion and Outcomes
RVAD implantation represents the pinnacle of modern mechanical circulatory support for right-sided heart failure. While the procedure is complex and carries inherent risks, the ability to provide hemodynamic stability to a failing right ventricle has revolutionized the prognosis for patients in cardiogenic shock. Success is heavily dependent on early intervention, meticulous surgical technique, and a dedicated multidisciplinary team. As technology advances, we expect to see smaller, more durable devices that will further improve the quality of life for these patients.
Disclaimer: This guide is intended for educational purposes for medical professionals and students. It does not replace institutional clinical protocols or individual surgeon judgment. Always refer to the specific device manufacturer’s manual for technical specifications.
